Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults

NCT02367638 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Varicella (Chicken Pox)

Interventions

BIOLOGICAL: MG1111
BIOLOGICAL: VARIVAX

Sponsor

Green Cross Corporation